4697 |
MitraClip and TMVR Complications and Failures |
Eberhard Grube |
Apr. 28. 18 |
4696 |
Mitral Valve-in-Mitral Annular Calcification (ViMAC): New Options |
Vinayak Bapat |
Apr. 28. 18 |
4695 |
Non-Femoral TAVR Access: Trans-Aortic, Trans-Caval, Trans-Carotid, Trans-Axillary, and More - Whom and How? |
Jian (James) Ye |
Apr. 28. 18 |
4694 |
TAVR ViV: Techniques and Data |
Owen Christopher Raffel |
Apr. 28. 18 |
4693 |
Inter-Atrial Shunts in HF: Devices, Indication, and Outcomes |
Gregg W. Stone |
Apr. 28. 18 |
4692 |
Role of TEE in Left Atrial Appendage Closure(LAAC): Lesson Learned |
Maurice Buchbinder |
Apr. 28. 18 |
4691 |
Watchman Asia Pacific Study(WASP): A Prospective 7 Country Multicentre Cohort Study, One Year Results |
Teguh Santoso |
Apr. 28. 18 |
4690 |
Leaflet Thrombosis, Clinical Relevance, and Optimal Antithrombotics: Updated Review and ADAPT-TAVR Trial |
Do-Yoon Kang |
Apr. 28. 18 |
4689 |
TAVR: Paravalvular Leak Closure |
Owen Christopher Raffel |
Apr. 28. 18 |
4688 |
TAVR for Pure AR |
Jian (James) Ye |
Apr. 28. 18 |